Decenes Group

Information sheet

These substances were identified for action under the Chemicals Management Plan (CMP).

Summary of publications
Substance group CAS RN Common name (acronym) DSL name Draft screening assessment Risk management scope Proposed conclusion on section 64 criteria Follow-up activities
Decenes Group 68649-11-6Table 1 Footnote a Hydrogenated didecene 1-Decene, dimer, hydrogenated HTML HTML Meets one or more of the criteria Refer to risk management scope
68649-12-7Table 1 Footnote a Hydrogenated trimer and tetramer of decene (HTTD) 1-Decene, tetramer, mixed with 1-decene trimer, hydrogenated
Table 1 Footnote a

This CAS RN is a UVCB (unknown or variable composition, complex reaction products, or biological materials).

Table 1 Return to footnote a referrer

Date Activity
January 2022 Anticipated publication of the final screening assessment and proposed risk management approach.
January 9, 2021 Publication and start of 60-day public comment period on the draft screening assessment and risk management scope. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 2.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: